# A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203

> **NCT01386567** · PHASE2 · COMPLETED · sponsor: **Repros Therapeutics Inc.** · enrollment: 48 (actual)

## Conditions studied

- Hypogonadism
- Low Testosterone

## Interventions

- **DRUG:** Androxal (enclomiphene citrate)
- **DRUG:** Testim (topical testosterone)

## Key facts

- **NCT ID:** NCT01386567
- **Lead sponsor:** Repros Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386567, "A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01386567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*